preclinical studies demonstrate that apple juice exerts multiple beneficial effects including reduction of central nervous system oxidative damage suppression of alzheimers disease ad hallmarks improved cognitive performance and organized synaptic signalingherein we initiated an openlabel clinical trial in which 21 institutionalized individuals with moderatetosevere ad consumed 2 4oz glasses of apple juice daily for 1 monthparticipants demonstrated no change in the dementia rating scale and institutional caregivers reported no change in alzheimers disease cooperative study adcsactivities of daily living adl in this brief studyhowever caregivers reported an approximate 27 p  01 improvement in behavioral and psychotic symptoms associated with dementia as quantified by the neuropsychiatric inventory with the largest changes in anxiety agitation and delusionthis pilot study suggests that apple juice may be a useful supplement perhaps to augment pharmacological approaches for attenuating the decline in mood that accompanies progression of ad which may also reduce caregiver burden